Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Drug Use To Increase In Japan

This article was originally published in PharmAsia News

Executive Summary

 
Advertisement

Related Content

MHLW Releases New Drug Pricing Report Amid Deadlock In Price Revision Exemption Debate
Japan’s 2007 Generic Sales Rise 9 Percent To ¥425 Billion
Teva And Kowa Partner For 50-50 Stake In Japanese Generic Firm
To Enter Japanese Generic Market, Quality Comes First, Experts Tell Indian Drug Makers
Astellas Expansion Of Domestic Sales Impressive Despite NHI Pricing; Launches Mycamine in U.K.
Dealmaker Breaks Down The Daiichi Sankyo-Ranbaxy Deal: PharmAsia News Spotlight
Shionogi Expects Crestor To Overtake Pfizer’s Lipitor
More Innovative Hypertension Treatments On The Horizon As Patents Expire In Japan
PharmAsia News Notable Notes: Japan’s Rising Health Care Funding Gap
Nichi-Iko Seeks To Acquire Teikoku Medix To Be Largest Japanese Generic
Advertisement
UsernamePublicRestriction

Register

SC068019

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel